Posterior capsule opacification after cataract surgery in patients with uveitis

被引:68
作者
Dana, MR
Chatzistefanou, K
Schaumberg, DA
Foster, CS
机构
[1] MASSACHUSETTS EYE & EAR INFIRM,UVETIS & IMMUNOL SERV,BOSTON,MA 02114
[2] MASSACHUSETTS EYE & EAR INFIRM,CORNEA SERV,BOSTON,MA 02114
[3] HARVARD UNIV,SCH MED,SCHEPENS EYE RES INST,BOSTON,MA
[4] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DIV OPHTHALMOL,BOSTON,MA 02115
[5] UNIV ATHENS,DEPT OPHTHALMOL,GR-10679 ATHENS,GREECE
[6] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DIV PREVENT MED,BOSTON,MA 02115
[7] HARVARD UNIV,SCH PUBL HLTH,DEPT EPIDEMIOL,BOSTON,MA 02115
关键词
D O I
10.1016/S0161-6420(97)30126-2
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To compare the incidence rate of posterior capsule opacification (PCO) after phacoemulsification and standard extracapsular cataract extraction (P/ECCE) in eyes with antecedent uveitis with the incidence rate in eyes without any history of intraocular inflammation. Design: Review of records of 108 eyes of 78 patients with uveitis and 122 eyes of 106 patients with no uveitis who underwent P/ECCE. Rates of PCO were compared by the log-rank test of differences in the Kaplan-Meier survival curves. Proportional hazards regression models provided estimates of the relative risks of PCO among uveitic compared to nonuveitic eyes. Main Outcome Measures: Performance of neodymium:YAG laser posterior capsulotomy was used as a proxy measure for the main outcome of visually significant PCO. Results: Study patients ranged in age from 6 to 81 years (median, 44.5 years) among those with uveitis and 27 to 96 years (median, 68.5 years) among those without uveitis (P = 0.0001). Crude incidence rates for visually significant PCO were 54% over a mean follow-up of 4.3 years in uveitic cases and 40% over a mean follow-up of 3.9 years among nonuveitic cases (P = 0.02). Estimates of PCO incidence (95% confidence interval) in uveitic eyes derived from the Kaplan-Meier models were 38.5% (range, 28.9%-48.2%) at 1 year and 56% (range, 45.8%-66.3%) at 3 years, and estimates among nonuveitic eyes were 11.5% (range, 6.2%-16.8%) at 1 year and 38.4% (range, 29%-47.8%) at 3 years. These rates of PCO among patients with uveitis and those patients without uveitis differed significantly by the log-rank test (P = 0.004). However, after adjusting for the younger age of patients with uveitis, the rates of PCO were no longer statistically different. Conclusions: The apparent higher rate of PCO in patients with uveitis is primarily due to their younger age at the time of surgery. A moderately increased independent risk of PCO from uveitis cannot, however, be ruled out by this study.
引用
收藏
页码:1387 / 1393
页数:7
相关论文
共 27 条
[1]   POSTERIOR CAPSULE OPACIFICATION [J].
APPLE, DJ ;
SOLOMON, KD ;
TETZ, MR ;
ASSIA, EI ;
HOLLAND, EY ;
LEGLER, UFC ;
TSAI, JC ;
CASTANEDA, VE ;
HOGGATT, JP ;
KOSTICK, AMP .
SURVEY OF OPHTHALMOLOGY, 1992, 37 (02) :73-116
[2]  
APPLE DJ, 1984, AM INTRA-OCUL IMPL J, V10, P53
[3]   INCIDENCE OF POSTOPERATIVE POSTERIOR CAPSULAR OPACIFICATION WITH TYPES OF SENILE CATARACTS [J].
ARGENTO, C ;
NUNEZ, E ;
WAINSZTEIN, R .
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 1992, 18 (06) :586-588
[4]   LONG-TERM RESULTS OF ND-YAG LASER POSTERIOR CAPSULOTOMY WITH THE SWISS LASER [J].
BATH, PE ;
FANKHAUSER, F .
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 1986, 12 (02) :150-153
[5]   EFFECT OF INTRAOCULAR-LENS OPTIC DESIGN ON POSTERIOR CAPSULAR OPACIFICATION [J].
BORN, CP ;
RYAN, DK .
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 1990, 16 (02) :188-192
[6]  
DIAMOND JG, 1978, ARCH OPHTHALMOL-CHIC, V96, P1798
[7]  
FLYNN HW, 1988, OPHTHALMOLOGY, V95, P1114
[8]   CATARACT-SURGERY AND INTRAOCULAR-LENS IMPLANTATION IN PATIENTS WITH UVEITIS [J].
FOSTER, CS ;
FONG, LP ;
SINGH, G .
OPHTHALMOLOGY, 1989, 96 (03) :281-287
[9]  
FOSTER CS, 1994, CATARACT SURG PATIEN
[10]  
Foster CS., 1993, OPHTHALMOL CLIN N AM, V6, P139